Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19

Clinical trial NCT04922814 · COMPLETED

Trial details

NCT number: NCT04922814
Sponsor: Assiut University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

COVID-19 Acute Respiratory Distress Syndrome Sedation Complication ICU Acquired Weakness

Start date: 2021-08-01
Primary completion: 2022-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.